2022
DOI: 10.1016/j.biomaterials.2022.121578
|View full text |Cite
|
Sign up to set email alerts
|

Extracellular vesicle-guided in situ reprogramming of synovial macrophages for the treatment of rheumatoid arthritis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
23
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 31 publications
(23 citation statements)
references
References 58 publications
0
23
0
Order By: Relevance
“…N/A M2 macrophage-derived EVs reprogrammed M1 macrophages within joints to quiescent, antiinflammatory M2 state leading to reduced inflammation. [185] DLS, dynamic light scattering; FACS, fluorescence activated cell sorting (flow cytometry); nanoFCM, nano-flow cytometry; NTA, nanoparticle tracking analysis; PET/CT, positron emission tomography/computed tomography; SEM, scanning electron microscopy; SLE, systemic lupus erythematosus; TEM, transmission electron microscopy; WB, western blotting.…”
Section: Rheumatoid Arthritismentioning
confidence: 99%
“…N/A M2 macrophage-derived EVs reprogrammed M1 macrophages within joints to quiescent, antiinflammatory M2 state leading to reduced inflammation. [185] DLS, dynamic light scattering; FACS, fluorescence activated cell sorting (flow cytometry); nanoFCM, nano-flow cytometry; NTA, nanoparticle tracking analysis; PET/CT, positron emission tomography/computed tomography; SEM, scanning electron microscopy; SLE, systemic lupus erythematosus; TEM, transmission electron microscopy; WB, western blotting.…”
Section: Rheumatoid Arthritismentioning
confidence: 99%
“…Notably, another study demonstrated the remarkable in situ macrophage-repolarizing capacity of M2-EVs, in which synovial macrophages switched from the M1 to M2 phenotype in a collagen-induced rheumatoid arthritis (RA) mouse model. 17 However, whether M2-EVs exert therapeutic effects in OA is not clear. Therefore, investigating the role of M2-EVs in macrophage reprogramming during OA progression and exploring their potential applications may lead to new therapeutic strategies for OA treatment.…”
Section: Introductionmentioning
confidence: 99%
“…Adaptive immune cells referring to B cells and T cells, are mainly responsible for mediating humoral immunity and cellular immunity, respectively ( 1 ). However, the chaotic responses of immune cells often lead to various inflammatory diseases like chronic wounds ( 2 ), rheumatoid arthritis ( 3 ), inflammatory bowel diseases ( 4 ), encephalomyelitis ( 5 ), and so on, imposing a heavy burden on the economy and society ( 6 , 7 ). For example, the unbalanced ratio of anti-inflammatory M2 macrophages (M2φ)/pro-inflammatory M1 macrophages (M1φ) or delayed transition from M1φ to M2φ phenotype of macrophages leads to excessive inflammation, impairing healing process of chronic wounds ( 8 ).…”
Section: Introductionmentioning
confidence: 99%